Lisnom Health develops transplant technology aimed at restoring function following spinal cord injuries. This solution addresses complex SCI symptoms such as chronic pain, mobility issues, and bowel/bladder dysfunction. The company focuses on extending healthy longevity through these innovative transplant solutions.
Funding
Funding not disclosed
Founders
Product
Problem
Spinal cord injuries (SCI) affect millions worldwide, leading to paralysis, chronic pain, and bowel/bladder dysfunction. Current treatments primarily manage symptoms, with no definitive cure available, resulting in high annual healthcare costs for patients.
Solution
Lisnom Health is developing a spinal cord transplant solution designed to restore function lost due to SCI. Their approach involves removing scar tissue within the injured spinal cord and transplanting healthy nerve tissue to facilitate functional recovery. The transplant aims to address a range of SCI-related symptoms, including pain, mobility issues, and bowel/bladder dysfunction, with the goal of providing a one-time curative treatment.
Target Audience
The primary target audience includes individuals suffering from spinal cord injuries (SCI) and the healthcare providers who treat them.
Features
- Surgical procedure involving the removal of scar tissue from the injured spinal cord.
- Transplantation of healthy nerve tissue to promote regeneration and functional recovery.
- Addresses multiple SCI symptoms, including paralysis, chronic pain, and bowel/bladder dysfunction.
- Aims to provide a one-time curative solution, reducing the need for ongoing symptom management.